+1 877 705 191424 / 7
HIPAA Compliant
ISO 27001 Certified

Status Unknown

Phase 3
Age: 25Years - 75Years
All Genders
ID00000149

Collaborative Initial Glaucoma Treatment Study (CIGTS)

Led by National Eye Institute (NEI) · Updated on 2005-06-24

N/A

Participants Needed

N/A

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

To compare the long-term effect of treating newly diagnosed open-angle glaucoma with standard medical treatment versus filtration surgery.

CONDITIONS

Brief Title

Collaborative Initial Glaucoma Treatment Study (CIGTS)

Who Can Participate

Age: 25Years - 75Years
All Genders

Eligibility Criteria

Patients must be at least 25 years old with an intraocular pressure of 20 mm Hg or greater and evidence of optic nerve damage and/or visual field loss in one or both eyes. The ocular findings must exclude causes of glaucoma other than primary open-angle glaucoma, pigmentary glaucoma, or pseudoexfoliation glaucoma.

Trial Site Locations

Site Locations not provided

Location information for this trial is currently unavailable.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here